FDA Approved: LYVISPAH — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved LYVISPAH (baclofen) from Amneal Pharmaceuticals LLC as an Original Application. It is indicated for the management of spasticity due to multiple sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spasticity
• Spinal Cord Injury

Drugs mentioned

• LYVISPAH (BACLOFEN)

Snippet

ORIG AP for LYVISPAH (BACLOFEN)